bf/NYSE:TEVA_icon.png

COM:TEVAPHARM

Teva Pharmaceutical Industries Ltd.

  • Stock

USD

Last Close

17.08

22/11 21:00

Market Cap

19.23B

Beta: -

Volume Today

6.01M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
20.31B
-
20.27B
0.21%
19.65B
3.06%
21.90B
11.45%
22.39B
2.20%
18.85B
15.77%
16.89B
10.43%
16.66B
1.36%
15.88B
4.68%
14.93B
6.00%
15.85B
6.17%
cost of revenue
9.61B
-
9.22B
4.07%
8.30B
9.98%
10.04B
21.07%
11.56B
15.09%
10.56B
8.67%
9.35B
11.43%
8.93B
4.47%
8.28B
7.27%
7.95B
4.01%
8.20B
3.13%
gross profit
10.71B
-
11.06B
3.26%
11.36B
2.71%
11.86B
4.43%
10.82B
8.72%
8.30B
23.36%
7.54B
9.16%
7.72B
2.51%
7.59B
1.70%
6.97B
8.18%
7.64B
9.64%
selling and marketing expenses
4.08B
-
3.86B
5.37%
3.48B
9.92%
3.86B
10.98%
3.66B
5.28%
2.92B
20.24%
2.61B
10.36%
2.50B
4.44%
2.43B
2.76%
2.27B
6.75%
2.34B
3.13%
general and administrative expenses
1.24B
-
1.22B
1.78%
1.24B
1.81%
1.24B
0.24%
1.33B
7.61%
1.30B
2.41%
1.19B
8.17%
1.17B
1.59%
1.10B
6.31%
1.18B
7.37%
1.16B
1.53%
selling general and administrative expenses
5.32B
-
5.08B
4.53%
4.72B
7.11%
5.10B
8.03%
4.99B
2.16%
4.21B
15.48%
3.81B
9.68%
3.67B
3.55%
3.53B
3.90%
3.44B
2.35%
3.50B
1.54%
research and development expenses
1.43B
-
1.49B
4.27%
1.52B
2.49%
2.11B
38.43%
1.85B
12.46%
1.21B
34.36%
1.01B
16.74%
997M
1.29%
967M
3.01%
838M
13.34%
953M
13.72%
other expenses
-36M
-
-17M
52.78%
23M
235.29%
636M
2,665.22%
1.20B
88.52%
291M
75.73%
76M
73.88%
-4M
105.26%
98M
2,550%
107M
9.18%
cost and expenses
16.35B
-
15.78B
3.49%
14.54B
7.88%
17.25B
18.66%
18.39B
6.63%
15.98B
13.10%
14.17B
11.37%
13.60B
4.00%
12.78B
6.04%
12.23B
4.26%
12.65B
3.41%
operating expenses
6.75B
-
6.57B
2.67%
6.24B
4.93%
7.21B
15.46%
6.83B
5.18%
5.43B
20.59%
4.82B
11.26%
4.67B
3.07%
4.50B
3.71%
4.28B
4.72%
4.45B
3.92%
interest expense
399M
-
313M
21.55%
1B
219.49%
1.33B
33%
895M
32.71%
959M
7.15%
822M
14.29%
963M
17.15%
1.06B
9.87%
966M
8.70%
ebitda
3.96B
-
4.49B
13.36%
5.11B
13.90%
4.65B
9.03%
5.19B
11.56%
3.16B
39.11%
3.21B
1.68%
4.61B
43.48%
4.53B
1.78%
4.11B
9.34%
433M
89.45%
operating income
1.65B
-
3.95B
139.60%
3.35B
15.16%
2.15B
35.74%
-17.48B
911.70%
-1.64B
90.64%
2.80B
270.86%
3.05B
9.15%
3.20B
4.75%
2.80B
12.54%
433M
84.52%
depreciation and amortization
1.64B
-
1.51B
8.16%
1.31B
13.26%
1.52B
16.51%
2.11B
38.58%
1.84B
12.78%
416M
77.42%
1.56B
274.28%
1.33B
14.58%
1.31B
1.65%
total other income expenses net
-2.31B
-
-539M
76.69%
-1.76B
226.90%
-2.50B
41.77%
-21.48B
759.69%
-4.51B
79.02%
-4.06B
9.85%
-7.46B
83.63%
-2.54B
65.95%
-5.86B
130.79%
-1.06B
81.97%
income before tax
1.25B
-
3.64B
191.04%
2.35B
35.35%
824M
64.97%
-18.38B
2,330.46%
-2.60B
85.88%
-1.26B
51.27%
-4.41B
248.30%
658M
114.93%
-3.06B
565.81%
-624M
79.64%
income tax expense
-43M
-
591M
1,474.42%
634M
7.28%
521M
17.82%
-1.93B
471.02%
-195M
89.91%
-278M
42.56%
-168M
39.57%
211M
225.60%
-638M
402.37%
-65M
89.81%
net income
1.27B
-
3.06B
140.74%
1.59B
48.02%
329M
79.28%
-16.27B
5,043.77%
-2.15B
86.78%
-999M
53.53%
-3.99B
299.40%
417M
110.45%
-2.35B
664.27%
-559M
76.24%
weighted average shs out
849M
-
853M
0.47%
855M
0.23%
955M
11.70%
1.02B
6.39%
1.02B
0.49%
1.09B
6.86%
1.09B
0.37%
1.10B
0.64%
1.11B
0.73%
1.12B
0.81%
weighted average shs out dil
850M
-
858M
0.94%
864M
0.70%
961M
11.23%
1.02B
5.72%
1.02B
0.49%
1.09B
6.86%
1.09B
0.37%
1.11B
1.10%
1.11B
0.27%
1.13B
1.89%
eps
1.49
-
3.58
140.27%
1.84
48.60%
0.07
96.20%
-16.01
22,971.43%
-2.11
86.82%
-0.92
56.40%
-3.64
295.65%
0.38
110.44%
-2.12
657.89%
-0.50
76.42%
epsdiluted
1.49
-
3.56
138.93%
1.82
48.88%
0.07
96.15%
-16.01
22,971.43%
-2.11
86.82%
-0.92
56.40%
-3.64
295.65%
0.38
110.44%
-2.12
657.89%
-0.49
76.89%

All numbers in USD (except ratios and percentages)